Weifeng Xu
ORCID: 0000-0003-0096-2288Also affiliated with Hainan University
Pilot corpus only
This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.
Indexed papers
Why this DataRank?
An author's DataRank is the sum of the DataRanks of all 1 indexed paper attributed to them. A prolific author with many moderate-impact papers can outrank one with a single high-impact paper.
Author scores recompute whenever paper DataRanks are refreshed, so this number lags the underlying paper scores by at most one batch run.
Read the full methodology →Papers
Driven by 3 papers. Top paper: “Microsatellite stable metastatic colorectal cancer without liver metastasis may be preferred population for regorafenib or fruquintinib plus sintilimab as third-line or above therapy:A real-world study”.
Huifang Lv, Beibei Chen, Weifeng Xu, Jianzheng Wang, Yingjun Liu +5 more
Siegrid Löwel, Oliver M. Schlüter, Weifeng Xu
Juliane M. Krüger, Anna Beroun, Weifeng Xu, Yan Dong, Oliver M. Schlüter +1 more